Arkolith/Insider Trading/RCUS/Form 4

Azoy Alexander

Chief Accounting OfficerArcus Biosciences, Inc. (RCUS) · full profile →Form 4 · filed Dec 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$195K
Net Open-Market Flow
-$195K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2025Sell(S)4K$22.25$97K19K
Dec 17, 2025Sell(S)2K$22.16$47K23K
Dec 16, 2025Sell(S)2K$21.88$52K25K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001771961-25-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML